Login to Your Account

Deal Includes $35M Up Front

Targacept NNR Platform Lands In Billion-Dollar GSK Alliance

By Jennifer Boggs

Monday, July 30, 2007
Targacept Inc. got an impressive stock boost Friday, jumping 20 percent on an early stage deal with GlaxoSmithKline plc to develop drugs targeting neuronal nicotinic receptors for pain and other disorders. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription